ArticleMolecular cancer therapeutics2025

Integration of Whole-Genome Sequencing Analysis with Unique Patient-Derived Models Reveals Clinically Relevant Drug Targets in TFCP2 Fusion-Defined Rhabdomyosarcoma.

Patrick Bergsma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.